Lenus Finvest Pvt Ltd's Insider Trades & SAST Disclosures
Lenus Finvest Pvt Ltd's most recent trade in Eiko Lifesciences Ltd. was a Acquisition of 200,000 Equity Shares done at an average price of Rs. 48.5 . Disclosure was reported to the exchange on May 15, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Lenus Finvest Pvt Ltd's has made SAST transactions in Eiko Lifesciences Ltd. recently where a Acquisition of 952,385 shares done . Disclosure was reported to the exchange on Nov. 22, 2024.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 29 Nov 2024 | 952,385 | 2,358,028 (18.94%) | 7.65% | - | 18 Nov 2024 18 Nov 2024 |
SAST (29(2)) | - | Open Offer | |
| Ganga Pharma | Lenus Finvest Pvt Ltd | Other | Acquisition | 08 Feb 2024 | 375,000 | 375,000 (7.75%) | 7.75% | - | 19 Jan 2024 19 Jan 2024 |
SAST (29(2)) | - | Pref. Allotment | |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 27 Feb 2023 | 10,000 | 843,386 (10.14%) | 0.12% | - | 22 Feb 2023 22 Feb 2023 |
SAST (29(2)) | - | Market | |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 01 Oct 2022 | 100,000 | 833,386 (10.02%) | 1.20% | - | 29 Sep 2022 29 Sep 2022 |
SAST (29(2)) | - | Market | |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 27 Sep 2022 | 100,000 | 733,386 (8.82%) | 1.20% | - | 26 Sep 2022 26 Sep 2022 |
SAST (29(2)) | - | Market | |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 15 May 2021 | 200,000 | 300,000 (7.86%) | 5.24% | 48.5 | 9,700,000 | 12 Mar 2021 12 Mar 2021 |
Insider Trading | Equity Shares | Market |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 15 May 2021 | 154,502 | 454,502 (11.90%) | 4.04% | 53.4 | 8,243,000 | 18 Mar 2021 18 Mar 2021 |
Insider Trading | Equity Shares | Market |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 15 May 2021 | 65,000 | 554,414 (14.51%) | 1.70% | 61.6 | 4,007,000 | 25 Mar 2021 25 Mar 2021 |
Insider Trading | Equity Shares | Market |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 15 May 2021 | 34,912 | 489,414 (12.81%) | 0.91% | 65.5 | 2,287,000 | 24 Mar 2021 24 Mar 2021 |
Insider Trading | Equity Shares | Market |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 26 Mar 2021 | 65,000 | 554,414 (14.51%) | 1.70% | - | 25 Mar 2021 25 Mar 2021 |
SAST (29(2)) | - | Market | |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 25 Mar 2021 | 34,912 | 489,414 (12.81%) | 0.91% | - | 23 Mar 2021 23 Mar 2021 |
SAST (29(2)) | - | Market | |
| Eiko Lifesciences | Lenus Finvest Pvt Ltd | Promoter | Acquisition | 19 Mar 2021 | 154,502 | 454,502 (11.90%) | 4.04% | - | 18 Mar 2021 18 Mar 2021 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.